The company declared a net profit of Rs 209.55 crore in the same period previous fiscal, Dr Reddy's Laboratories said in a filing to the Bombay Stock Exchange (BSE).

Dr Reddy's Labratories net income from sales and services stood at Rs 1,978.32 crore for the quarter ending on June 30, 2011, compared to Rs 1,683.13 crore for the same period previous fiscal. Meanwhile on a standalone basis, the company reported a net profit of Rs 454.05 crore for the first quarter ended June 30, 2011, compared to Rs 244.48 crore in the same period previous fiscal.

The company's net sales stood at Rs 1,675.71 crore for the first quarter on a standalone basis, compared to Rs 1,256.22 crore in the same period previous fiscal.

During the quarter, the company launched 39 new generic products, filed 31 new product registrations and nine drug master files globally, it said.

OneIndia Money